Stephen Davis Net Worth & Insider Trades

Stephen Davis - CEO, Acadia Pharmaceuticals Inc

As of July 18, 2023

What is Stephen Davis's Net Worth?

The current estimated net worth of Acadia Pharmaceuticals Inc's CEO, Stephen Davis, is estimated to be about $30.61M . Stephen Davis owns about 36,695 units of Acadia Pharmaceuticals Inc common stock. In the last 9 years at Acadia Pharmaceuticals Inc, Stephen Davis has sold an estimated value of $30.35M worth.

What is Stephen Davis's Past Insider Trading?

Stephen Davis's largest purchase order was 200,000 units , worth over $3.93M on May 15, 2020. Stephen Davis's largest sale order was 200,000 units , worth over $9.2M on May 15, 2020. In total, Stephen Davis has made about 33 transactions over 9 years of their time at Acadia Pharmaceuticals Inc. Stephen Davis usually trades in May and October, with the busiest year in 2023. The most recent transaction was a sale order of 100,000 units , worth over $3M on July 18, 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

STEPHEN DAVIS

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Stephen Davis's' Mailing Address?

  • Mailing address is Acadia Pharmaceuticals Inc. 12830 el Camino Real, Suite 400 San Diego CA 92130 CA

What are Acadia Pharmaceuticals Inc's Past Insider Trades?

Acadia Pharmaceuticals Inc's most recent insider trade came on September 19, 2023 by James Kihara who sold 2,000 units worth $51.76K . In the last 19 years, insiders at Acadia Pharmaceuticals Inc have sold an estimated value of $131.38M and bought an estimated value of $629.01M worth of shares. Insider trading is most common in June, with the busiest year in 2013. The most active traders at the company are Uli Hacksell, CEO,  Glenn Baity, EVP AND GC,  and Stephen Davis, CEO .

ACADIA PHARMACEUTICALS INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...